Literature DB >> 33202215

Furin Protease: From SARS CoV-2 to Anthrax, Diabetes, and Hypertension.

Kara Fitzgerald1.   

Abstract

Furin is a protease that is ubiquitous in mammalian metabolism. One of the innovations that make sudden acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) more infectious than its ancestor viruses is the addition of a furin cleavage site. Conditions associated with elevated furin levels, including diabetes, obesity, and hypertension, overlap greatly with vulnerability to the severe form of coronavirus disease 2019 (COVID-19). We suggest that diet and lifestyle modifications that reduce the associated comorbidities may prevent the development of severe COVID-19 by, in part, lowering circulating furin levels. Likewise, natural and pharmaceutical inhibitors of furin may be candidate prophylactic interventions or, if used early in the COVID-19, may prevent the development of critical symptoms.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33202215      PMCID: PMC7671676          DOI: 10.7812/TPP/20.187

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  17 in total

Review 1.  Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.

Authors:  Eakachai Prompetchara; Chutitorn Ketloy; Tanapat Palaga
Journal:  Asian Pac J Allergy Immunol       Date:  2020-03       Impact factor: 2.310

2.  Proprotein convertase inhibitory activities of flavonoids isolated from Oroxylum indicum.

Authors:  S Majumdar; B C Mohanta; D R Chowdhury; R Banik; B Dinda; A Basak
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 3.  Anthrax X-rayed: new opportunities for biodefence.

Authors:  Milton T Stubbs
Journal:  Trends Pharmacol Sci       Date:  2002-12       Impact factor: 14.819

Review 4.  The factor VIII protein and its function.

Authors:  Anna Mazurkiewicz-Pisarek; Grażyna Płucienniczak; Tomasz Ciach; Andrzej Płucienniczak
Journal:  Acta Biochim Pol       Date:  2016-01-28       Impact factor: 2.149

5.  The association between treatment with heparin and survival in patients with Covid-19.

Authors:  Luis Ayerbe; Carlos Risco; Salma Ayis
Journal:  J Thromb Thrombolysis       Date:  2020-05-31       Impact factor: 2.300

Review 6.  Furin-mediated protein processing in infectious diseases and cancer.

Authors:  Elisabeth Braun; Daniel Sauter
Journal:  Clin Transl Immunology       Date:  2019-08-05

7.  Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality.

Authors:  C Fernandez; J Rysä; P Almgren; J Nilsson; G Engström; M Orho-Melander; H Ruskoaho; O Melander
Journal:  J Intern Med       Date:  2018-07-02       Impact factor: 8.989

8.  The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade.

Authors:  B Coutard; C Valle; X de Lamballerie; B Canard; N G Seidah; E Decroly
Journal:  Antiviral Res       Date:  2020-02-10       Impact factor: 5.970

9.  FURIN variant associations with postexercise hypotension are intensity and race dependent.

Authors:  Burak T Cilhoroz; Elizabeth D Schifano; Gregory A Panza; Garrett I Ash; Lauren Corso; Ming-Hui Chen; Ved Deshpande; Amanda Zaleski; Paulo Farinatti; Lucas P Santos; Beth A Taylor; Rachel J O'Neill; Paul D Thompson; Linda S Pescatello
Journal:  Physiol Rep       Date:  2019-02

10.  The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases?

Authors:  F B Belen-Apak; F Sarialioglu
Journal:  Med Hypotheses       Date:  2020-04-20       Impact factor: 1.538

View more
  3 in total

1.  Discovery of diminazene as a dual inhibitor of SARS-CoV-2 human host proteases TMPRSS2 and furin using cell-based assays.

Authors:  Ya-Ming Xu; Marielle Cascaes Inacio; Manping X Liu; A A Leslie Gunatilaka
Journal:  Curr Res Chem Biol       Date:  2022-03-14

Review 2.  The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2.

Authors:  Gary Thomas; Frédéric Couture; Anna Kwiatkowska
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 6.208

Review 3.  Impact of SARS-CoV-2 on Host Factors Involved in Mental Disorders.

Authors:  Raina Rhoades; Sarah Solomon; Christina Johnson; Shaolei Teng
Journal:  Front Microbiol       Date:  2022-04-04       Impact factor: 6.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.